Now, in its seventh year, the Grass Roots event—organized annually by The Chromatographic Society—continues to offer a unique ...

An antisense oligonucleotide demonstrated a favorable safety profile and its disease-halting effect in one patient suggests ...

Phenomenex Inc., a Danaher Company, a global leader in the research and manufacture of advanced technologies for the separation sciences, has announced the expansion of its product portfolio at ASMS ...

Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that the Company granted an aggregate of 23,820 restricted stock units (“RSUs”) to six newly-hired non-executive employees under the Company’s ...

Major players including AbbVie, GSK, Sanofi, and Eli Lilly recently bolstered their R&D pipelines with a wave of acquisitions ...

Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts.

Angelman syndrome is a rare neurogenetic disorder affecting approximately 1 in 15,000 live births or 500,000 people globally.

Jonah Kirkwood, Agilent’s chief commercial officer, emphasized the company’s focus on high-growth markets and its dedication to partnering closely with customers to address their changing needs.